Medtronic plc Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q2 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Medtronic plc quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q2 2014 to Q2 2024.
  • Medtronic plc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending July 26, 2024 was $950M, a 54.2% increase year-over-year.
  • Medtronic plc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending July 26, 2024 was $4.19B, a 122% increase year-over-year.
  • Medtronic plc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was $3.86B, a 52.8% increase from 2022.
  • Medtronic plc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was $2.52B, a 59.7% decline from 2021.
  • Medtronic plc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was $6.26B, a 70% increase from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $4.19B $950M +$334M +54.2% Apr 27, 2024 Jul 26, 2024 10-Q 2024-08-27
Q1 2024 $3.86B $794M -$76M -8.74% Jan 27, 2024 Apr 26, 2024 10-K 2024-06-20
Q4 2023 $3.93B $1.24B +$846M +215% Oct 28, 2023 Jan 26, 2024 10-Q 2024-02-27
Q3 2023 $3.09B $1.21B +$1.2B +24020% Jul 29, 2023 Oct 27, 2023 10-Q 2023-11-30
Q2 2023 $1.89B $616M -$639M -50.9% Apr 29, 2023 Jul 28, 2023 10-Q 2024-08-27
Q1 2023 $2.52B $870M -$1.23B -58.6% Jan 28, 2023 Apr 28, 2023 10-K 2024-06-20
Q4 2022 $3.75B $394M -$1.25B -76% Oct 29, 2022 Jan 27, 2023 10-Q 2024-02-27
Q3 2022 $5B $5M -$1.47B -99.7% Jul 30, 2022 Oct 28, 2022 10-Q 2023-11-30
Q2 2022 $6.47B $1.26B +$216M +20.8% Apr 30, 2022 Jul 29, 2022 10-Q 2023-08-31
Q1 2022 $6.26B $2.1B +$302M +16.8% Jan 29, 2022 Apr 29, 2022 10-K 2024-06-20
Q4 2021 $5.96B $1.64B +$451M +37.9% Oct 30, 2021 Jan 28, 2022 10-Q 2023-03-01
Q3 2021 $5.51B $1.48B +$1.05B +245% Jul 31, 2021 Oct 29, 2021 10-Q 2022-12-01
Q2 2021 $4.46B $1.04B +$774M +292% May 1, 2021 Jul 30, 2021 10-Q 2022-09-01
Q1 2021 $3.68B $1.8B +$2.17B Jan 30, 2021 Apr 30, 2021 10-K 2023-06-22
Q4 2020 $1.52B $1.19B -$790M -39.9% Oct 31, 2020 Jan 29, 2021 10-Q 2022-03-03
Q3 2020 $2.31B $428M -$809M -65.4% Aug 1, 2020 Oct 30, 2020 10-Q 2021-12-02
Q2 2020 $3.11B $265M -$826M -75.7% Apr 25, 2020 Jul 31, 2020 10-Q 2021-09-02
Q1 2020 $3.94B -$368M -$1.29B -140% Jan 25, 2020 Apr 24, 2020 10-K 2022-06-23
Q4 2019 $5.23B $1.98B +$557M +39.1% Oct 26, 2019 Jan 24, 2020 10-Q 2021-03-05
Q3 2019 $4.67B $1.24B +$411M +49.8% Jul 27, 2019 Oct 25, 2019 10-Q 2020-12-03
Q2 2019 $4.26B $1.09B +$600M +122% Apr 27, 2019 Jul 26, 2019 10-Q 2020-09-03
Q1 2019 $3.66B $919M -$340M -27% Jan 26, 2019 Apr 26, 2019 10-K 2021-06-25
Q4 2018 $4B $1.42B +$2.13B Oct 27, 2018 Jan 25, 2019 10-Q 2020-02-28
Q3 2018 $1.87B $826M -$1.06B -56.1% Jul 28, 2018 Oct 26, 2018 10-Q 2019-12-03
Q2 2018 $2.92B $491M -$1.21B -71.2% Apr 28, 2018 Jul 27, 2018 10-Q 2019-08-30
Q1 2018 $4.13B $1.26B -$170M -11.9% Jan 27, 2018 Apr 27, 2018 10-K 2020-06-19
Q4 2017 $4.3B -$711M -$981M -363% Oct 28, 2017 Jan 26, 2018 10-Q 2019-03-01
Q3 2017 $5.29B $1.88B +$1.07B +132% Jul 29, 2017 Oct 27, 2017 10-Q 2018-11-29
Q2 2017 $4.22B $1.71B +$932M +121% Apr 29, 2017 Jul 28, 2017 10-Q 2018-08-31
Q1 2017 $3.28B $1.43B -$771M -35% Jan 28, 2017 Apr 28, 2017 10-K 2019-06-21
Q4 2016 $4.05B $270M +$669M Oct 29, 2016 Jan 27, 2017 10-Q 2018-03-02
Q3 2016 $3.39B $811M +$406M +100% Jul 30, 2016 Oct 28, 2016 10-Q 2017-12-04
Q2 2016 $2.98B $773M +$125M +19.3% Apr 30, 2016 Jul 29, 2016 10-Q 2017-09-01
Q1 2016 $2.85B $2.2B +$2.72B Jan 30, 2016 Apr 29, 2016 10-K 2018-06-22
Q4 2015 $130M -$399M -$1.22B -149% Oct 31, 2015 Jan 29, 2016 10-Q 2017-03-03
Q3 2015 $1.35B $405M -$405M -50% Aug 1, 2015 Oct 30, 2015 10-Q 2016-12-05
Q2 2015 $1.76B $648M -$332M -33.9% Apr 25, 2015 Jul 31, 2015 10-Q 2016-09-07
Q1 2015 $2.09B -$524M Jan 24, 2015 Apr 24, 2015 10-K 2017-06-27
Q4 2014 $822M Oct 25, 2014 Jan 23, 2015 10-Q 2016-03-09
Q3 2014 $810M Jul 26, 2014 Oct 24, 2014 10-Q 2015-12-09
Q2 2014 $980M Apr 26, 2014 Jul 25, 2014 10-Q 2015-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.